CD8A and COVID-19: A significantly lower CD4/CD8 ratio was found in severe or fatal ASyS+COVID compared to non-ASyS IIM donors with moderate COVID-19 (Supplementary Figure S2C), suggesting that the prominent loss of CD4+ T cells and relative expansion of CD8+ T cells is a distinct feature of high-risk ASyS suffered from COVID-19.